Eculizumab and refractory membranoproliferative glomerulonephritis
S Radhakrishnan, A Lunn, M Kirschfink… - … England Journal of …, 2012 - Mass Medical Soc
S Radhakrishnan, A Lunn, M Kirschfink, P Thorner, D Hebert, V Langlois, F Pluthero, C Licht
New England Journal of Medicine, 2012•Mass Medical SocEculizumab and Refractory Membranoproliferative Glomerulonephritis | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to
become a physician, build your knowledge, lead a health care organization, and advance your
career with NEJM Group information and services. NEJM Evidence NEW! A digital journal for
innovative original research and fresh, bold ideas in clinical trial design and clinical
decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to …
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to
become a physician, build your knowledge, lead a health care organization, and advance your
career with NEJM Group information and services. NEJM Evidence NEW! A digital journal for
innovative original research and fresh, bold ideas in clinical trial design and clinical
decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to …
This letter to the editor discusses the use of eculizumab in refractory membranoproliferative glomerulonephritis. The response appears to be dramatic.
The New England Journal Of Medicine